BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

Bio-Techne (NASDAQ: TECH) has announced its participation in three upcoming investor conferences in November 2024.

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced its participation in three upcoming investor conferences in November 2024. The company will present at the UBS Global Healthcare Conference on November 12 at 9:30 AM PST, the Stifel 2024 Healthcare Conference on November 19 at 8:00 AM EST, and the Stephens NASH 2024 Conference on November 20 at 11:00 AM CST. Interested parties can access live webcasts of all presentations through Bio-Techne's Investor Relations website's IR Calendar page.

Argus Publication session

-0.60% session move Open Argus

Details

News Market Reaction – TECH

In the trading session that priced this news, TECH declined 0.60%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

UBS Global Healthcare Conference
November 12, 2024
9:30 AM PST

Stifel 2024 Healthcare Conference
November 19, 2024
8:00 AM EST

Stephens NASH 2024 Conference
November 20, 2024
11:00 AM CST

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact:	David Clair, Vice President, Investor Relations & Corporate Development
	david.clair@bio-techne.com
	612-656-4416

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302298610.html

SOURCE Bio-Techne Corporation

FAQ

When is Bio-Techne (TECH) presenting at the UBS Global Healthcare Conference in 2024?

Bio-Techne (TECH) will present at the UBS Global Healthcare Conference on November 12, 2024, at 9:30 AM PST.

Which investor conferences will Bio-Techne (TECH) attend in November 2024?

Bio-Techne (TECH) will attend three conferences: UBS Global Healthcare Conference, Stifel 2024 Healthcare Conference, and Stephens NASH 2024 Conference.

How can investors access Bio-Techne's (TECH) conference presentations in November 2024?

Investors can access live webcasts of Bio-Techne's presentations through the IR Calendar page on the company's Investor Relations website at investors.bio-techne.com/ir-calendar.

What time is Bio-Techne's (TECH) presentation at the Stephens NASH 2024 Conference?

Bio-Techne (TECH) will present at the Stephens NASH 2024 Conference on November 20, 2024, at 11:00 AM CST.